Table 1.
Characteristics of study cohort
| Characteristic | N of patients |
GPER-1 |
p-value | |
|---|---|---|---|---|
|
Negative |
Positive |
|||
| N (%) | N (%) | |||
| Total |
124 |
21 (16.9) |
103 (83.1) |
|
| Age, years (range) |
124 |
65 (30–84) |
61 (20–85) |
0.136 |
| Menopausal status |
|
|
|
|
| premenopausal |
16 |
1 (6.2) |
15 (93.8) |
|
| postmenopausal |
108 |
20 (18.5) |
88 (81.5) |
0.304 |
| FIGO Stage |
|
|
|
|
| 1 |
25 |
0 (0) |
25 (100) |
|
| 2 |
21 |
6 (28.6) |
15 (71.4) |
|
| 3 |
76 |
14 (18.4) |
62 (81.6) |
|
| 4 |
2 |
1 (50.0) |
1 (50) |
0.032 |
| Lymph node status |
|
|
|
|
| negative |
31 |
5 (16.1) |
26 (83.9) |
|
| positive |
18 |
3 (16.7) |
15 (83.3) |
1.000 |
| Histological grading |
|
|
|
|
| 1 |
18 |
0 (0) |
18 (100) |
|
| 2 |
38 |
7 (18.4) |
31 (81.6) |
|
| 3 |
68 |
14 (20.6) |
54 (79.4) |
0.112 |
| Histology |
|
|
|
|
| serous |
81 |
13 (16.0) |
68 (84.0) |
|
| mucinous |
16 |
3 (18.8) |
13 (81.2) |
|
| endometrioid |
13 |
2 (15.4) |
11 (84.6) |
|
| clear cell |
8 |
0 (0) |
8 (100) |
|
| other |
6 |
3 (50) |
3 (50) |
0.171 |
| Recurrence (in 24 months) |
|
|
|
|
| no |
57 |
4 (7.0) |
53 (93.0) |
|
| yes | 67 | 17 (25.4) | 50 (74.6) | 0.008 |